about
Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain.Cost-effectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis.Pharmacoeconomics of empirical antifungal use in febrile neutropenic hematological malignancy and hematopoietic stem cell transplant patients.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacoeconomics of voriconazole.
@en
Pharmacoeconomics of voriconazole.
@nl
type
label
Pharmacoeconomics of voriconazole.
@en
Pharmacoeconomics of voriconazole.
@nl
prefLabel
Pharmacoeconomics of voriconazole.
@en
Pharmacoeconomics of voriconazole.
@nl
P2860
P1476
Pharmacoeconomics of voriconazole.
@en
P2093
Carlos Rubio-Terrés
Santiago Grau
P2860
P304
P356
10.1517/14656561003649555
P407
P577
2010-04-01T00:00:00Z